Mariam Wael

Al Ahly Pharos Securities Brokerage

Equity Research Analyst @ Al Ahly Pharos Securities Brokerage

Mariam is an Equity Research Analyst at Pharos Holding, focusing on the Egyptian market. She holds a bachelor's degree – majoring in Finance and minoring in Financial Economics. 

Mariam Wael
Hide filters Show filters
Latest articles from Mariam Wael

Egypt Pharma 2022: Well positioned for recovery, supported by favorable dynamics

Egypt is the MEA region’s largest producer and second largest consumer of pharmaceuticals, growing at a CAGR of 17% over 2013a-2020a, surpassing the region’s CAGR of 8%. Despite pressure during the past couple of years because of the pandemic, we for...
Al Ahly Pharos Securities Brokerage Mariam
Mariam Wael @ Al Ahly Pharos Securities Brokerage 25 November 2021

Cleopatra Hospitals Group: Robust performance despite sequential decline on a relatively weaker July

During the quarter, revenue growth was capped by a relatively weaker July, that witnessed a significant decline in covid-related revenues and holidays observed in July. Cleopatra Hospital (which includes revenues generated by Queens Hospital, a Covid...
Al Ahly Pharos Securities Brokerage Mariam
Mariam Wael @ Al Ahly Pharos Securities Brokerage 21 November 2021

MM Group: Weak Seasonality of Auto and Huawei Caps Revenue Growth; Alpha is in Ebtikar

MTIE reported 3Q2021 revenues of EGP2.24 billion (in line with our estimates of EGP2.20 billion), compared to EGP2.21 billion in 3Q20 and compared to EGP2.32 billion in 2Q21 (+1.6% YoY, -3.4% QoQ). The annual decline is mainly attributed to Huawei we...
Al Ahly Pharos Securities Brokerage Mariam
Mariam Wael @ Al Ahly Pharos Securities Brokerage 16 November 2021

Rameda Pharmaceuticals: Private sales drive revenue growth, solid bottom line growth

The retail pharma market continued to sequentially recover during 9M21, which confirms the sustainability of the gradual sequential recovery expected in 4Q21. During 3Q21, RMDA’s private sales recorded EGP240 million (+27.2% YoY, +35.9% QoQ), where v...
Al Ahly Pharos Securities Brokerage Mariam
Mariam Wael @ Al Ahly Pharos Securities Brokerage 16 November 2021

IbnSina Pharma: Solid operational performance confirms a better outlook for 2022

Retail pharma market continued to sequentially recover during 9M21, which confirms the sustainability of the gradual sequential recovery expected in 4Q21. ISPH reported 9M21 net revenues of EGP15.75 billion (in line with our estimates of EGP15.90 bn)...
Al Ahly Pharos Securities Brokerage Mariam
Mariam Wael @ Al Ahly Pharos Securities Brokerage 15 November 2021

Telecom Egypt: Solid Revenues, Margin Expansion, Lower Debt on Vodafone Special Dividends

ETEL reported 3Q21 revenues of EGP9.0 billion, compared to EGP7. Home and consumer data continued to drive growth during 3Q21 (+25.6% YoY, +6.3% QoQ), fueled by a growth of 16.4% YoY and 2.9% QoQ in Home and Consumer ADSL subscribers to stand at 7.4 ...
Al Ahly Pharos Securities Brokerage Mariam
Mariam Wael @ Al Ahly Pharos Securities Brokerage 11 November 2021

Filter by tags

Africa
MENA
Mariam Wael
Egypt
Equity
2020
2019
Communication Services
2021
Health Care
Media & Entertainment
1Q20
2018
Middle East